Sanofi-Aventis to buy Chattem for $1.9 billions

December 21, 2009 07:19 pm | Updated 07:22 pm IST - Paris

A file picture of Dr. Shailesh Ayyangar, Managing Director, Sanofi Aventis, in Mumbai. Photo: Paul Noronha.

A file picture of Dr. Shailesh Ayyangar, Managing Director, Sanofi Aventis, in Mumbai. Photo: Paul Noronha.

French drug maker Sanofi—Aventis SA says it has agreed to buy US healthcare company Chattem Inc. for about $1.9 billions in cash in a deal it said would create the world’s fifth—largest consumer healthcare company.

Paris—based Sanofi—Aventis says it will offer $93.50 per share to acquire 100 percent of Chattem, a Chattanooga, Tennessee based maker of consumer healthcare products such as Gold Bond skin care creams and Icy Hot pain relief medicine.

In a statement on Monday, Sanofi—Aventis said it will launch its public tender offer for Chattem in January, and it expects to complete the acquisition in the first quarter of 2010.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.